FSCN1 and female reproductive organ cancer: Numerous studies have reported overexpression of FSCN1 in various gynecological cancers [123,125,126,127,128,129,130,131,132,133,134,135,136,137,138,139,140,141,142,143,144,145,146,147] as indicated in Table 1.